創薬インフォマティクス(情報科学)の世界市場予測(~2022年)

MarketsandMarketsが発行した調査報告書(MAM-HIT-5838)
◆英語タイトル:Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022
◆商品コード:MAM-HIT-5838
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2017年12月18日
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:IT
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

MarketsandMarketsが発行した当調査レポートでは、創薬インフォマティクス(情報科学)の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、機能別分析、ソリューション別分析、需要先別分析、地域別分析、創薬インフォマティクス(情報科学)の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・創薬インフォマティクス(情報科学)の世界市場:市場インサイト
・創薬インフォマティクス(情報科学)の世界市場:市場概観/市場動向
・創薬インフォマティクス(情報科学)の世界市場:機能別分析/市場規模
・創薬インフォマティクス(情報科学)の世界市場:ソリューション別分析/市場規模
・創薬インフォマティクス(情報科学)の世界市場:需要先別分析/市場規模
・創薬インフォマティクス(情報科学)の世界市場:地域別分析/市場規模
・創薬インフォマティクス(情報科学)のアジア市場規模予測
・創薬インフォマティクス(情報科学)のヨーロッパ市場規模予測
・創薬インフォマティクス(情報科学)のアメリカ市場規模予測
・創薬インフォマティクス(情報科学)の世界市場動向
・創薬インフォマティクス(情報科学)の世界市場:競争状況
・創薬インフォマティクス(情報科学)の世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

“The global drug discovery informatics market is projected to grow at a CAGR of 11.2%.”The global drug discovery informatics market is expected to reach USD 2.84 billion in 2022 from USD 1.67 billion in 2017 at a CAGR of 11.2%. Growth in the drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs. Impending patent expiries and the growing biotechnology industry are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, the scarcity of skilled professionals and the high pricing and setup cost of informatics software are both factors that are expected to limit market growth to a certain extent.

“The sequencing and target data analysis segment is expected to account for the largest share in 2017.”
On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.
“The software segment is expected to account for the largest share in 2017.”
On the basis of solution, the market is classified into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.
“North America is expected to account for the largest share during the forecast period.”
By geography, North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

Break-up profile of primaries:
• By Company Type- Tier 1-45%, Tier 2-34% and Tier 3-21%
• By Designation-C-level-36%, D-level-40% and Others-24%
• By Region-North America-40%, Europe-22%, Asia Pacific-30%, and RoW-8%
The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrodinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

Research Coverage:
The drug discovery informatics market in this report is segmented by function, solution, end user, and region. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the drug discovery informatics market.
Reasons to buy this report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on portfolios offered by the top players in the global drug discovery informatics market. The report analyzes the market by function, solution, end user, and region

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global drug discovery informatics market

• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for global discovery informatics products across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global drug discovery informatics market

• Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global drug discovery informatics market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 MARKET SCOPE 12
1.3.1 MARKETS COVERED 12
1.3.2 YEARS CONSIDERED FOR THE STUDY 12
1.4 CURRENCY 13
1.5 LIMITATIONS 13
1.6 STAKEHOLDERS 13
2 RESEARCH METHODOLOGY 14
2.1 RESEARCH DATA 14
2.1.1 SECONDARY DATA 15
2.1.1.1 Secondary sources 15
2.1.2 PRIMARY DATA 15
2.1.2.1 Key data from primary sources 16
2.1.2.2 Key industry insights 17
2.2 MARKET SIZE ESTIMATION 18
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.4 ASSUMPTIONS 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 25
4.1 DRUG DISCOVERY INFORMATICS: MARKET OVERVIEW 25
4.2 ASIA PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION AND END USER 26
4.3 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 27
4.4 GEOGRAPHICAL SNAPSHOT OF THE DRUG DISCOVERY INFORMATICS MARKET 27
5 MARKET OVERVIEW 28
5.1 INTRODUCTION 28
5.2 MARKET DYNAMICS 28
5.2.1 DRIVERS 29
5.2.1.1 Rising R&D expenditure 29
5.2.1.2 Increasing focus on drug discovery 29
5.2.1.3 Need to control drug discovery and development costs 30
5.2.2 RESTRAINT 30
5.2.2.1 High pricing and setup cost of informatics software 30
5.2.3 OPPORTUNITIES 30
5.2.3.1 Patent expiry 30
5.2.3.2 Growing biotechnology industry 31
5.2.4 CHALLENGE 31
5.2.4.1 Scarcity of skilled professionals 31
6 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 32
6.1 INTRODUCTION 33
6.2 SEQUENCING & TARGET DATA ANALYSIS 34
6.3 DOCKING 36
6.4 MOLECULAR MODELLING 37
6.5 LIBRARIES & DATABASE PREPARATION 39
6.6 OTHER FUNCTIONS 40
7 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 42
7.1 INTRODUCTION 43
7.2 SOFTWARE 43
7.3 SERVICES 45
8 DRUG DISCOVERY INFORMATICS MARKET, BY END USER 47
8.1 INTRODUCTION 48
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 48
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 50
8.4 OTHER END USERS 52
9 DRUG DISCOVERY INFORMATICS MARKET, BY REGION 54
9.1 INTRODUCTION 55
9.2 NORTH AMERICA 56
9.2.1 US 58
9.2.2 CANADA 60
9.3 EUROPE 62
9.3.1 GERMANY 63
9.3.2 REST OF EUROPE 65
9.4 ASIA PACIFIC (APAC) 67
9.5 REST OF THE WORLD 70
10 COMPETITIVE LANDSCAPE 72
10.1 OVERVIEW 72
10.2 RANKING OF PLAYERS, 2016 73
10.3 COMPETITIVE SCENARIO 74
10.3.1 COLLABORATIONS, PARTNERSHIPS, AGREEMENTS, & ACQUISITIONS 74
10.3.2 EXPANSIONS 75
10.3.3 PRODUCT LAUNCHES & ENHANCEMENTS 75
11 COMPANY PROFILES 76
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 JUBILANT LIFE SCIENCES 76
11.2 IBM 79
11.3 INFOSYS 82
11.4 THERMO FISHER SCIENTIFIC 85
11.5 PERKINELMER 88
11.6 SCHRÖDINGER 91
11.7 DASSAULT SYSTÈMES 93
11.8 CHARLES RIVER LABORATORIES 95
11.9 SELVITA 97
11.10 CERTARA 99
11.11 GVK BIOSCIENCES 100
11.12 COLLABORATIVE DRUG DISCOVERY 101
11.13 OPENEYE SCIENTIFIC SOFTWARE 102
11.14 IO INFORMATICS 103
11.15 NOVO INFORMATICS 104

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 105
12.1 INSIGHTS OF INDUSTRY EXPERTS 105
12.2 DISCUSSION GUIDE 106
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 109
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 111
12.5 AVAILABLE CUSTOMIZATIONS 113
12.6 RELATED REPORTS 114
12.7 AUTHOR DETAILS 115

LIST OF TABLES

TABLE 1 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION,
2015–2022 (USD MILLION) 33
TABLE 2 DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2015–2022 (USD MILLION) 34
TABLE 3 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2015–2022 (USD MILLION) 35
TABLE 4 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2015–2022 (USD MILLION) 35
TABLE 5 DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION,
2015–2022 (USD MILLION) 36
TABLE 6 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING,
BY COUNTRY, 2015–2022 (USD MILLION) 36
TABLE 7 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING,
BY COUNTRY, 2015–2022 (USD MILLION) 37
TABLE 8 DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING,
BY REGION, 2015–2022 (USD MILLION) 37
TABLE 9 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY COUNTRY, 2015–2022 (USD MILLION) 38
TABLE 10 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY COUNTRY, 2015–2022 (USD MILLION) 38
TABLE 11 DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARIES & DATABASE PREPARATION, BY REGION, 2015–2022 (USD MILLION) 39
TABLE 12 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARIES & DATABASE PREPARATION, BY COUNTRY, 2015–2022 (USD MILLION) 39
TABLE 13 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARIES & DATABASE PREPARATION, BY COUNTRY, 2015–2022 (USD MILLION) 40
TABLE 14 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS,
BY REGION, 2015–2022 (USD MILLION) 41
TABLE 15 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2015–2022 (USD MILLION) 41
TABLE 16 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS,
BY COUNTRY, 2015–2022 (USD MILLION) 41
TABLE 17 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,
2015–2022 (USD MILLION) 43
TABLE 18 DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE,
BY REGION, 2015–2022 (USD MILLION) 43
TABLE 19 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE,
BY COUNTRY, 2015–2022 (USD MILLION) 44
TABLE 20 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE,
BY COUNTRY, 2015–2022 (USD MILLION) 44
TABLE 21 DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY REGION,
2015–2022 (USD MILLION) 45
TABLE 22 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES,
BY COUNTRY, 2015–2022 (USD MILLION) 45
TABLE 23 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES,
BY COUNTRY, 2015–2022 (USD MILLION) 46
TABLE 24 DRUG DISCOVERY INFORMATICS MARKET, BY END USER,
2015–2022 (USD MILLION) 48
TABLE 25 DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION) 49
TABLE 26 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2015–2022 (USD MILLION) 49
TABLE 27 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION) 49
TABLE 28 DRUG DISCOVERY INFORMATICS MARKET FOR CROS, BY REGION,
2015–2022 (USD MILLION) 50
TABLE 29 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR CROS,
BY COUNTRY, 2015–2022 (USD MILLION) 51
TABLE 30 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR CROS,
BY COUNTRY, 2015–2022 (USD MILLION) 51
TABLE 31 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS,
BY REGION, 2015–2022 (USD MILLION) 52
TABLE 32 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY, 2015–2022 (USD MILLION) 52
TABLE 33 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS,
BY COUNTRY, 2015–2022 (USD MILLION) 53
TABLE 34 DRUG DISCOVERY INFORMATICS MARKET, BY REGION,
2015–2022 (USD MILLION) 55
TABLE 35 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET,
BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 36 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET,
BY FUNCTION, 2015–2022 (USD MILLION) 57
TABLE 37 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET,
BY SOLUTION, 2015–2022 (USD MILLION) 57
TABLE 38 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET,
BY END USER, 2015–2022 (USD MILLION) 58
TABLE 39 US: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION,
2015–2022 (USD MILLION) 59
TABLE 40 US: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,
2015–2022 (USD MILLION) 59
TABLE 41 US: DRUG DISCOVERY INFORMATICS MARKET, BY END USER,
2015–2022 (USD MILLION) 60
TABLE 42 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION,
2015–2022 (USD MILLION) 60
TABLE 43 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,
2015–2022 (USD MILLION) 61
TABLE 44 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER,
2015–2022 (USD MILLION) 61
TABLE 45 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 62
TABLE 46 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION,
2015–2022 (USD MILLION) 62
TABLE 47 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,
2015–2022 (USD MILLION) 63
TABLE 48 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER,
2015–2022 (USD MILLION) 63
TABLE 49 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION,
2015–2022 (USD MILLION) 64
TABLE 50 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,
2015–2022 (USD MILLION) 64
TABLE 51 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY END USER,
2015–2022 (USD MILLION) 65
TABLE 52 REST OF EUROPE: DRUG DISCOVERY INFORMATICS MARKET,
BY FUNCTION, 2015–2022 (USD MILLION) 65
TABLE 53 REST OF EUROPE: DRUG DISCOVERY INFORMATICS MARKET,
BY SOLUTION, 2015–2022 (USD MILLION) 66
TABLE 54 REST OF EUROPE: DRUG DISCOVERY INFORMATICS MARKET,
BY END USER, 2015–2022 (USD MILLION) 66
TABLE 55 ASIA PACIFIC: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION,
2015–2022 (USD MILLION) 68
TABLE 56 ASIA PACIFIC: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,
2015–2022 (USD MILLION) 68
TABLE 57 ASIA PACIFIC: DRUG DISCOVERY INFORMATICS MARKET, BY END USER,
2015–2022 (USD MILLION) 69
TABLE 58 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION,
2015–2022 (USD MILLION) 70
TABLE 59 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,
2015–2022 (USD MILLION) 70
TABLE 60 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY END USER,
2015–2022 (USD MILLION) 71
TABLE 61 COLLABORATIONS, PARTNERSHIPS, AGREEMENTS, & ACQUISITIONS,
2015–2017 74
TABLE 62 EXPANSIONS, 2015–2017 75
TABLE 63 PRODUCT LAUNCHES & ENHANCEMENTS, 2015–2017 75


LIST OF FIGURES

FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 17
FIGURE 3 BOTTOM UP APPROACH 19
FIGURE 4 TOP DOWN APPROACH 19
FIGURE 6 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION,
2017 VS. 2022 (USD BILLION) 22
FIGURE 7 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,
2017 VS. 2022 (USD BILLION) 23
FIGURE 8 DRUG DISCOVERY INFORMATICS MARKET, BY END USER,
2017 VS. 2022 (USD BILLION) 23
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF DRUG DISCOVERY INFORMATICS MARKET
(2017-2022) 24
FIGURE 10 RISING FOCUS ON REDUCING OPERATIONAL COSTS—A PRIMARY GROWTH DRIVER OF THE DRUG DISCOVERY INFORMATICS MARKET 25
FIGURE 11 SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE THE DRUG DISCOVERY INFORMATICS MARKET IN 2022 27
FIGURE 12 APAC WILL BE THE FASTEST-GROWING MARKET FROM 2017 TO 2022 27
FIGURE 13 DRUG DISCOVERY INFORMATICS MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES 28
FIGURE 14 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2022 (USD BILLION) 29
FIGURE 15 DRUG DISCOVERY INFORMATICS FUNCTION 33
FIGURE 16 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT 56
FIGURE 17 ASIA PACIFIC: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT 67
FIGURE 18 COMPANIES ADOPTED PRODUCT LAUNCHES, EXPANSIONS, COLLABORATIONS, PARTNERSHIPS, AGREEMENTS, AND ACQUISITIONS AS THEIR KEY GROWTH STRATEGY BETWEEN 2014-2017 72
FIGURE 19 JUBILANT LIFE SCIENCES: COMPANY SNAPSHOT (2017) 76
FIGURE 20 IBM: COMPANY SNAPSHOT (2016) 79
FIGURE 21 INFOSYS: COMPANY SNAPSHOT (2016) 82
FIGURE 22 THERMO FISHER: COMPANY SNAPSHOT (2016) 85
FIGURE 23 PERKINELMER: COMPANY SNAPSHOT (2016) 88
FIGURE 24 DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2016) 93
FIGURE 25 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2016) 95
FIGURE 26 SELVITA: COMPANY SNAPSHOT (2016) 97


【レポートのキーワード】

創薬インフォマティクス、新薬開発、情報科学、データ分析、ソフトウェア、創薬サービス

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 創薬インフォマティクス(情報科学)の世界市場予測(~2022年)(Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆